|
Market Closed -
Euronext Paris
03:55:00 20/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 19.10 EUR | 0.00% |
|
+0.26% | -36.96% |
| 18/09 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 23/04 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 332M 364M 307M 277M 521M 33.98B 542M 3.7B 1.46B 18.34B 1.36B 1.34B 57.91B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 284M 311M 262M 237M 446M 29.08B 464M 3.17B 1.25B 15.69B 1.17B 1.14B 49.56B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
12.84% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
| BOIp | Real-time | ||
| BON | Delayed | ||
| 0DTF | Real-time | ||
| BON | Delayed | ||
| BON | Real-time |
| 1 week | +0.26% | ||
| Current month | +2.14% | ||
| 1 month | +5.23% | ||
| 3 months | -27.10% | ||
| 6 months | -28.73% | ||
| Current year | -36.96% |
| 1 week | 18.85 | 19.25 | |
| 1 month | 17.45 | 20.3 | |
| Current year | 16.9 | 30.95 | |
| 1 year | 16.9 | 32.25 | |
| 3 years | 16.9 | 42.8 | |
| 5 years | 16.9 | 56.5 | |
| 10 years | 16.9 | 92.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/10/23 | Sell | Director | 198,664 | 1.1323% | ||
| 29/10/23 | Sell | Director | 462,964 | 2.6387% | ||
| 29/10/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +0.26% | -28.86% | -52.06% | 364M | ||
| -1.54% | -5.01% | +29.17% | +126.86% | 1,232B | ||
| -1.93% | -5.81% | +31.87% | +78.13% | 656B | ||
| -1.09% | -4.11% | +21.23% | +104.15% | 506B | ||
| -1.04% | -1.80% | +28.69% | +68.33% | 382B | ||
| -2.84% | -8.95% | +40.77% | +30.31% | 340B | ||
| -3.22% | -5.20% | +24.48% | +50.97% | 294B | ||
| -2.51% | -4.49% | -2.15% | +31.64% | 278B | ||
| -0.76% | -5.96% | +28.28% | +65.52% | 240B | ||
| -0.95% | -0.60% | +30.35% | +119.66% | 210B | ||
| Average | -1.61% | -2.15% | +20.38% | +62.35% | 414B | |
| Weighted average by Cap. | -1.79% | -2.67% | +27.10% | +87.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 535M 451M 407M 766M 49.96B 796M 5.44B 2.15B 26.96B 2.01B 1.96B 85.15B | 501M 549M 463M 418M 787M 51.34B 819M 5.6B 2.21B 27.71B 2.06B 2.02B 87.51B |
| Net income | 11.34M 12.43M 10.48M 9.46M 17.81M 1.16B 18.52M 127M 50.04M 627M 46.63M 45.65M 1.98B | 32.64M 35.79M 30.18M 27.24M 51.3M 3.34B 53.32M 365M 144M 1.81B 134M 131M 5.7B |
| Net Debt | -49.74M -54.54M -45.99M -41.5M -78.16M -5.1B -81.24M -555M -220M -2.75B -205M -200M -8.69B | -47.86M -52.47M -44.25M -39.93M -75.2M -4.9B -78.17M -534M -211M -2.65B -197M -193M -8.36B |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | EUR 19.10 | 0.00% | 258 |
| 18/11/26 | EUR 19.10 | -0.78% | 649 |
| 17/11/26 | EUR 19.25 | +1.32% | 1,291 |
| 16/11/26 | EUR 19.00 | -1.04% | 1,591 |
| 13/11/26 | EUR 19.20 | +0.79% | 1,710 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions
















